Fused ring compound having urea structure
The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating / preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular di...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TSUJI, TAKASHI NAKAMURA, TSUYOSHI TERAYAMA, KOJI TANAKA, JUN AKIU, MAYUKO YOKOYAMA, MIKA PINKERTON, ANTHONY B SESSIONS, EDWARD HAMPTON |
| description | The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating / preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: wherein A, B, R1, R2 and R3 represent the same meanings as in the claims. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202019902A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202019902A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202019902A3</originalsourceid><addsrcrecordid>eNrjZNB0Ky1OTVEoysxLV0jOzy3IL81LUchILAPxS4tSExWKS4pKk0uATB4G1rTEnOJUXijNzaDo5hri7KGbWpAfn1pckJicmpdaEh8SbmRgZGBoaWlg5GhMjBoAEuEo_Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fused ring compound having urea structure</title><source>esp@cenet</source><creator>TSUJI, TAKASHI ; NAKAMURA, TSUYOSHI ; TERAYAMA, KOJI ; TANAKA, JUN ; AKIU, MAYUKO ; YOKOYAMA, MIKA ; PINKERTON, ANTHONY B ; SESSIONS, EDWARD HAMPTON</creator><creatorcontrib>TSUJI, TAKASHI ; NAKAMURA, TSUYOSHI ; TERAYAMA, KOJI ; TANAKA, JUN ; AKIU, MAYUKO ; YOKOYAMA, MIKA ; PINKERTON, ANTHONY B ; SESSIONS, EDWARD HAMPTON</creatorcontrib><description>The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating / preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: wherein A, B, R1, R2 and R3 represent the same meanings as in the claims.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200601&DB=EPODOC&CC=TW&NR=202019902A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200601&DB=EPODOC&CC=TW&NR=202019902A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TSUJI, TAKASHI</creatorcontrib><creatorcontrib>NAKAMURA, TSUYOSHI</creatorcontrib><creatorcontrib>TERAYAMA, KOJI</creatorcontrib><creatorcontrib>TANAKA, JUN</creatorcontrib><creatorcontrib>AKIU, MAYUKO</creatorcontrib><creatorcontrib>YOKOYAMA, MIKA</creatorcontrib><creatorcontrib>PINKERTON, ANTHONY B</creatorcontrib><creatorcontrib>SESSIONS, EDWARD HAMPTON</creatorcontrib><title>Fused ring compound having urea structure</title><description>The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating / preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: wherein A, B, R1, R2 and R3 represent the same meanings as in the claims.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB0Ky1OTVEoysxLV0jOzy3IL81LUchILAPxS4tSExWKS4pKk0uATB4G1rTEnOJUXijNzaDo5hri7KGbWpAfn1pckJicmpdaEh8SbmRgZGBoaWlg5GhMjBoAEuEo_Q</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>TSUJI, TAKASHI</creator><creator>NAKAMURA, TSUYOSHI</creator><creator>TERAYAMA, KOJI</creator><creator>TANAKA, JUN</creator><creator>AKIU, MAYUKO</creator><creator>YOKOYAMA, MIKA</creator><creator>PINKERTON, ANTHONY B</creator><creator>SESSIONS, EDWARD HAMPTON</creator><scope>EVB</scope></search><sort><creationdate>20200601</creationdate><title>Fused ring compound having urea structure</title><author>TSUJI, TAKASHI ; NAKAMURA, TSUYOSHI ; TERAYAMA, KOJI ; TANAKA, JUN ; AKIU, MAYUKO ; YOKOYAMA, MIKA ; PINKERTON, ANTHONY B ; SESSIONS, EDWARD HAMPTON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202019902A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TSUJI, TAKASHI</creatorcontrib><creatorcontrib>NAKAMURA, TSUYOSHI</creatorcontrib><creatorcontrib>TERAYAMA, KOJI</creatorcontrib><creatorcontrib>TANAKA, JUN</creatorcontrib><creatorcontrib>AKIU, MAYUKO</creatorcontrib><creatorcontrib>YOKOYAMA, MIKA</creatorcontrib><creatorcontrib>PINKERTON, ANTHONY B</creatorcontrib><creatorcontrib>SESSIONS, EDWARD HAMPTON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TSUJI, TAKASHI</au><au>NAKAMURA, TSUYOSHI</au><au>TERAYAMA, KOJI</au><au>TANAKA, JUN</au><au>AKIU, MAYUKO</au><au>YOKOYAMA, MIKA</au><au>PINKERTON, ANTHONY B</au><au>SESSIONS, EDWARD HAMPTON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fused ring compound having urea structure</title><date>2020-06-01</date><risdate>2020</risdate><abstract>The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating / preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: wherein A, B, R1, R2 and R3 represent the same meanings as in the claims.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202019902A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Fused ring compound having urea structure |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A32%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TSUJI,%20TAKASHI&rft.date=2020-06-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202019902A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |